Thats a good point, but I dont look at it that way... No matter how the numbers are gathered, they all add up together in the same filing
When i look at a company, i look at the OVERALL health. The numbers are the only way to tell if a company even has the resources/ability to get to the next level... and when i look at the health of these other MJ plays, i cant find anything in the position AMFE is in
Being a NET profitable stock allows AMFE to develop/sell their MJ tech without a heavy drain (dilution) on shareholders... and imo GROzone has as much, if not the most potential of any product i have seen these public MJ companies push. There are not many MJ related patents in the sector and i bet GZ has some of the best margins out of all of them. ONE contract is all we need to make the first $$$ for GZ and i have no doubt its coming. They just started pushing the new system.
Half of these MJ plays were mining stocks or some other flavor-of-the-day not long ago... They become an MJ company so insiders could use the hype to leach off their shareholders. Many investors are going to get raked across the coals if they hold them longer than the pumps. Choosing wisely is very important for a long hold
People think cultivation is where the money is, but that is the WORST place to invest in the USA sector (Canada limits their grower permits)... Growing MJ is relatively easy and with 10's of thousands of growers popping up, they are flooding the market and destroying margins and it will get worse when the testing regulations kick in... One has to be selective to make $$$ long term and the only way to run a tight margin business successfully, is to reduce risks = Hello GROzone!
PS: I use to think testing was where the $$$ was in the sector, but there is too much overhead and capacity restraints to run a lab... which is why i sold my testing stock and put that money here. Enjoy your day
My postings contain many opinions. So please do your own research
and validation.
AI
Market Data 
Markets 
